Ataxia telangiectasia (AT) is a multi-faceted autosomal disease in which homozygous affected individuals have high cancer rates and extreme radiation sensitivity. Although the AT disease is a rare entity, AT heterozygotes may constitute an estimated 1.4% of the population, and show a familial disposition to breast cancer. Furthermore, epidemiological studies by Swift have suggested more than 7% of patients with breast cancer may be heterozygotes for ATM. Patients who are heterozygotes for ATM may be more sensitive to exposure to high doses of ionizing radiation, constituting a subpopulation at risk for radiation complications. Positional cloning has recently yielded the (ATM) gene sequence that is mutated in AT patients, opening a tremendous opportunity to experimentally address questions on the role of ATM in breast cancer epidemiology, and its significance to diagnostic and therapeutic ionizing radiation used in breast cancer patients. We propose to evaluate the presence of a mutated gene (ATM) in a prospective clinical trial of 200 patients undergoing radiation therapy to the breast for carcinoma. We will monitor acute skin reactions, and identify ATM mutations using RT-PCR, SSCP, PTT and sequence analysis. We will correlate clinical observations to molecular findings to provide evidence in support or against the hypotheses that (1) AT heterozygotes comprise a more """"""""radiation sensitive"""""""" cohort of patients, and (2) that patients with breast cancer have a higher incidence of AT heterozygosity. Furthermore, a positive correlation of ATM mutations to acute radiation reactions will form the basis for ATM as a possible predictive assay for breast cancer patients undergoing diagnostic and therapeutic radiation applications.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA074175-05
Application #
6443863
Study Section
Project Start
2001-04-02
Project End
2002-08-31
Budget Start
1997-10-01
Budget End
1998-09-30
Support Year
5
Fiscal Year
2001
Total Cost
$348,824
Indirect Cost
Name
Georgetown University
Department
Type
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Sakabe, Isamu; Hu, Rong; Jin, Lu et al. (2015) TMEM33: a new stress-inducible endoplasmic reticulum transmembrane protein and modulator of the unfolded protein response signaling. Breast Cancer Res Treat 153:285-97
Zhang, Chuanbo; Kallakury, Bhaskar V; Ross, Jeffrey S et al. (2013) The significance of TNFAIP8 in prostate cancer response to radiation and docetaxel and disease recurrence. Int J Cancer 133:31-42
Cheema, Amrita K; Varghese, Rency S; Timofeeva, Olga et al. (2013) Functional proteomics analysis to study ATM dependent signaling in response to ionizing radiation. Radiat Res 179:674-683
Jung, Mira; Timofeeva, Olga; Cheema, Amrita K et al. (2011) Human fibroblasts for large-scale ""omics"" investigations of ATM gene function. Adv Exp Med Biol 720:181-90
Cheema, Amrita K; Timofeeva, Olga; Varghese, Rency et al. (2011) Integrated analysis of ATM mediated gene and protein expression impacting cellular metabolism. J Proteome Res 10:2651-7
Konsoula, Zacharoula; Velena, Alfredo; Lee, Rachel et al. (2011) Histone deacetylase inhibitor: antineoplastic agent and radiation modulator. Adv Exp Med Biol 720:171-9
Hu, Zhang-Zhi; Huang, Hongzhan; Wu, Cathy H et al. (2011) Omics-based molecular target and biomarker identification. Methods Mol Biol 719:547-71
Varghese, Rency S; Cheema, Amrita; Cheema, Prabhdeep et al. (2010) Analysis of LC-MS data for characterizing the metabolic changes in response to radiation. J Proteome Res 9:2786-93
Broustas, Constantinos G; Ross, Jeffrey S; Yang, Qifeng et al. (2010) The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival. Clin Cancer Res 16:2939-48
Agbor-Enoh, S; Seudieu, C; Davidson, E et al. (2009) Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice. Antimicrob Agents Chemother 53:1727-34

Showing the most recent 10 out of 103 publications